Overview

Study to Evaluate the Efficacy and Safety of PB-201 in Type 2 Diabetic Mellitus Patients With Poor Glycemic Control Via Metformin Hydrochloride Monotherapy

Status:
Not yet recruiting

Trial end date:
2024-10-31

Target enrollment:

Participant gender:

Summary

This is a Multi-center, Randomized, Double-Blinded, Parallel and Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of PB-201 in Type 2 Diabetic Mellitus Patients with Poor Glycemic Control via Metformin Hydrochloride Monotherapy

Phase:

Phase 3

Details

Lead Sponsor:

PegBio Co., Ltd.

Treatments:

Metformin